Literature DB >> 34141056

Combination Therapy of RNA Interference and Small Molecules for Treating Hepatitis B Virus Infection.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34141056      PMCID： PMC8201480          DOI： 10.1021/acsmedchemlett.1c00103

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  5 in total

Review 1.  Can we cure hepatitis B virus with novel direct-acting antivirals?

Authors:  Maria G Martinez; François Villeret; Barbara Testoni; Fabien Zoulim
Journal:  Liver Int       Date:  2020-02       Impact factor: 5.828

Review 2.  Recent advances in the development of HBV capsid assembly modulators.

Authors:  Bhavitavya Nijampatnam; Dennis C Liotta
Journal:  Curr Opin Chem Biol       Date:  2019-04-02       Impact factor: 8.822

Review 3.  Discovery and optimization of benzenesulfonamides-based hepatitis B virus capsid modulators via contemporary medicinal chemistry strategies.

Authors:  Yujie Ren; Yue Ma; Srinivasulu Cherukupalli; John E Tavis; Luis Menéndez-Arias; Xinyong Liu; Peng Zhan
Journal:  Eur J Med Chem       Date:  2020-08-05       Impact factor: 6.514

Review 4.  Viral structural proteins as targets for antivirals.

Authors:  Christopher John Schlicksup; Adam Zlotnick
Journal:  Curr Opin Virol       Date:  2020-08-07       Impact factor: 7.090

Review 5.  Medicinal chemistry strategies toward host targeting antiviral agents.

Authors:  Xingyue Ji; Zhuorong Li
Journal:  Med Res Rev       Date:  2020-02-14       Impact factor: 12.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.